Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels

Atherosclerosis

Volumn 218, Issue 1, 2011, Pages 226-232

  Nakatani, Kazuhiro ^a   Sugimoto, Taizo ^b   Masuda, Daisaku ^a   Okano, Rieko ^c   Oya, Tomoko ^c   Monden, Yasumasa ^c   Yamashita, Taiji ^a   Kawase, Ryota ^a   Nakaoka, Hajime ^a   Inagaki, Miwako ^a   Yuasa Kawase, Miyako ^a   Tsubakio Yamamoto, Kazumi ^a   Ohama, Tohru ^a   Nishida, Makoto ^a,d   Ishigami, Masato ^a   Komuro, Issei ^a   Yamashita, Shizuya ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sugimoto Clinic   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Apolipoprotein B 48; Atherosclerosis; Carotid intima media thickness; Chylomicron remnants; Postprandial hyperlipidemia

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; BIOCHEMICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; EARLY DIAGNOSIS; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEIN B-48; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL; CHYLOMICRONS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; PARTICLE SIZE; POSTPRANDIAL PERIOD; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 80052273752     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.05.009     Document Type: Article

References (29)

1. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971, 74(1):1-12.
2. LaRosa J.C., Grundy S.M., Waters D.D., et al. Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005, 352(14):1425-1435.
3. Albrink M.J., Man E.B. Serum triglycerides in coronary artery disease. AMA Arch Intern Med 1959, 103(1):4-8.
4. Austin M.A. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991, 11(1):2-14.
5. Eberly L.E., Stamler J., Neaton J.D. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med 2003, 163(9):1077-1083.
6. Iso H., Naito Y., Sato S., et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 2001, 153(5):490-499.
7. Castelli W.P. Lipids, risk factors and ischamemic heart disease. Atherosclerosis 1996, 124(SUPPL.):S1-9.
8. Mori Y., Itoh Y., Komiya H., et al. Association between postprandial remnant-like particle triglyceride (RLP-TG) levels and carotid intima-media thickness (IMT) in Japanese patients with type 2 diabetes: assessment by meal tolerance tests (MTT). Endocrine 2005, 28(2):157-163.
9. Patsch J.R., Miesenböck G., Hopferwieser T., et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992, 12(11):1336-1345.
10. Ryu J.E., Howard G., Craven T.E., et al. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992, 23(6):823-828.
11. Fujioka Y., Ishikawa Y. Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb 2009, 16(3):145-154.
12. Sakai N., Uchida Y., Ohashi K., et al. Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res 2003, 44(6):1256-1262.
13. Smith D., Watts G.F., Dane-Stewart C., et al. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state. Eur J Clin Invest 1999, 29(3):204-209.
14. Karpe F., de Faire U., Mercuri M., et al. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. Atherosclerosis 1998, 141(2):307-314.
15. Mero N., Malmström R., Steiner G., et al. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000, 150(1):167-177.
16. Meyer E., Westerveld H.T., de Ruyter-Meijstek F.C., et al. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis 1996, 124(2):221-235.
17. Tanimura K., Nakajima Y., Nagao M., et al. Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus. Diabetes Res Clin Pract 2008, 81(3):338-344.
18. Bots M.L., Hoes A.W., Koudstaal P.J., et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997, 96(5):1432-1437.
19. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997, 146(6):483-494.
20. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 1979, 60(3):473-485.
21. Pal S., Semorine K., Watts G.F., et al. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med 2003, 41(6):792-795.
22. Fujioka Y., Cooper A.D., Fong L.G. Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages. J Lipid Res 1998, 39(12):2339-2349.
23. Domoto K., Taniguchi T., Takaishi H., et al. Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells. Atherosclerosis 2003, 171(2):193-200.
24. Takahashi Y., Fujioka Y., Takahashi T., et al. Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells. Life Sci 2005, 77(6):670-682.
25. Morimoto S., Fujioka Y., Hosoai H., et al. The renin-angiotensin system is involved in the production of plasminogen activator inhibitor type 1 by cultured endothelial cells in response to chylomicron remnants. Hypertens Res 2003, 26(4):315-323.
26. Kawasaki S., Taniguchi T., Fujioka Y., et al. Chylomicron remnant induces apoptosis in vascular endothelial cells. Ann N Y Acad Sci 2000, 902:336-341.
27. Simon A., Gariepy J., Chironi G., et al. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002, 20(2):159-169.
28. Masuda D., Nakagawa-Toyama Y., Nakatani K., et al. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia. Euro J Clin Invest 2009, 39(8):689-698.
29. Syvänne M., Taskinen M.R. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 1997, 350:20-23.